MétaCan
Menu
Back to cohort
Record W7037370114

Editorial, News, Bio shares

2010· article· en· W7037370114 on OpenAlexaboutno aff

Bibliographic record

VenueTSpace (University of Toronto) · 2010
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicTransgenic Plants and Applications
Canadian institutionsnot available
Fundersnot available
KeywordsStock (firearms)Investment (military)AgricultureCredibilityTourism
DOInot available

Abstract

fetched live from OpenAlex

Australasian Biotechnology, Volume 7 Number 2, March/April 1997,\npp.66-86 & 108-123 Editorial, News, Bio shares Code Number: AU97011\nSize of Files: Text: 117.1K Graphics: No associated graphics files FROM\nTHE PRESIDENT Agricultural Biotechnology Needs Investment Not\nAdditional Regulation I was recently browsing on the world wide web and\ncame across a list of `Agricultural Biotechnology Products Expected on\nthe Market Within Six Years'. There were over twenty-five different\ntypes of product ranging from late ripening fruits (bananas,\nstrawberries, raspberries, tomatoes), vegetables with enhanced\nproperties (such as the potato with higher density starch that when\ndeep fried takes up less fat; and peppers that are sweeter firmer and\ntastier) and of course a range of disease resistant or herbicide\nresistant crop plants. There was even a tree that had modified lignin,\nfacilitating its easy removal from cellulose and therefore requiring\nless energy and bleaching resulting in benefits to both the paper\nprocessor and the environment. NEWS $44m in R&D Start large grants\nannounced The Industry Research and Development Board announced on 19th\nMarch successful recipients of grants under the first round of the\nR&D Start program - large grants element. Sixteen projects have\nbeen offered a total of $44 million. Biota Announces Zanamivir Will\nEnter Phase III Clinical Trials in May 1997 Biota Holdings Limited\n(Australian Stock Exchange: BTA) announced on 24th February that Glaxo\nWellcome plc, the Company's development partner, has informed\nmanagement that Phase III clinical trials of zanamivir, or GG167, for\nthe treatment of influenza, planned to start in 1997, will begin in\nAustralia in May. This Southern Hemisphere trial will be a part of a\ncomprehensive world-wide Phase III programme which will also include\ntwo separate pivotal proof of efficacy studies to be initiated in the\nNorthern Hemisphere from October of this year. Dolly - The Science\nBehind the Sensation Moratorium Reaction Responses in the US Australia\nUrged to Back Winners Fish Studies Reveal the Good Oil Collaborators\nSought for the Roslin and Moredun Stress Proteins and Human Ageing\nHuman Hemoglobin-producing Tobacco The Biotechnology Industry\nOrganization (BIO) and SciQuest(sm) to form Internet Partnership\nBioethical Aspects of Biotechnology in the Agrofood Sector - Developing\nCountries MORE DOLLY NEWS Dolly Cloning Raises Ire of Anti Biotech\nLobby Nuclear Transfer in Humans Position Statement on Cloning by the\nCouncil for Responsible Genetics New Pharmaceutical Policies LATE NEWS\nNew Company - Enzyme Solutions Pty Ltd COMPANY NEWS Peptech awarded\nMajor Grant for Drug Development New $3.5 Million Microbiology Plant\nPlanned for Brisbane "START" Program Funding for Biotech Australia\nRancoo Changes its Name and Appoints a New CEO Profile: Dr Paul\nTolstoshev, BresaGen Sheep Cloning an "Important Step" in Transplant\nResearch - Geneticist AGEN Reports Break-even Result New Drug Blows\nAway Cold and Flu Symptoms BIO SHARES Covering Australian Biotechnology\nStocks - compiled by M.J. Playne Introducing a New Corporate Member\nGist-brocades in Australia The People and Gist-brocades The Products\nCultures Ingredients Preservation Tests Quality Assurance ASIAN NEWS\nAsian Bioscience Improving Rapidly but Still has a Long Way to Go Foot\nand mouth disease has finally hit Taiwan after 63 years of absence.\nREGULATORY NEWS USA EPA Issues New Notification and Screening\nRequirements for Microbial Biotech Products Canadian Biotech\nRegulations PATENT NEWS Contributed by Dr. Vivien Santer Extension of\nPatent Term Re-Instated Discussion Paper on Patentability Standards\nOfficial Fees in the European Patent Office being Reduced Philippines\nto Adopt First to File System Supreme Court Upholds Doctrine of\nEquivalents in the United States General Patent News ABA NEWS\nBiotechnology Industry Organization (BIO) AusBiotech Alliance\nSubmissions to Government Reviews Gene Technology Authority Regional\nMeetings BIO Meeting News from New Zealand by Ian Maddox, President,\nNew Zealand Biotechnology Association Annual General Meeting PRODUCT\nNEWS Pall and Gelman Sciences Complete Merger Crown Scientific The\nEppendorf Model 5171 Micromanipulator The Cell Becomes a Test Tube\nEppendorf Release the Titerman for Low Volume Ranges of 0.5 uL to 10 uL\nTrace Scientific Assayed Cardiac Enzyme Control Mettler Toledo ATCC\nExpress-CheckTM Kit ATCC Introduces VitaCellTM Cell Culture Media &\nSerum Scientific Associates Stedim Flexboy and Biopharm Sterile Carboys\nCopyright 1997 Australian Biotechnology Association Ltd.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.853
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.007
GPT teacher head0.225
Teacher spread0.218 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2010
Admission routes1
Has abstractyes

Explore more

Same venueTSpace (University of Toronto)Same topicTransgenic Plants and ApplicationsFrench-language works237,207